Hundreds Of Open Access Journals Accept Fake Science Paper

(Last Updated On: October 4, 2013)

Hundreds of open access journals, including those published by industry giants Sage, Elsevier and Wolters Kluwer, have accepted a fake scientific paper in a sting operation that reveals the “contours of an emerging wild west in academic publishing”.

The hoax, which was set up by John Bohannon, a science journalist at Harvard University, saw various versions of a bogus scientific paper being submitted to 304 open access journals worldwide over a period of 10 months.

The paper, which described a simple test of whether cancer cells grow more slowly in a test tube when treated with increasing concentrations of a molecule, had “fatal flaws” and used fabricated authors and universities with African affiliated names, Bohannon revealed in Science magazine.

He wrote: “Any reviewer with more than a high-school knowledge of chemistry and the ability to understand a basic data plot should have spotted the paper’s shortcomings immediately. Its experiments are so hopelessly flawed that the results are meaningless.”

Bohannon, who wrote the paper, submitted around 10 articles per week to open access journals that use the ‘gold’ open access route, which requires the author to pay a fee if the paper is published.

The “wonder drug paper” as he calls it, was accepted by 157 of the journals and rejected by 98. Of the 255 versions that went through the entire editing process to either acceptance or rejection, 60% did not undergo peer review. Of the 106 journals that did conduct peer review, 70% accepted the paper.

Public Library of Science, PLOS ONE, was the only journal that called attention to the paper’s potential ethical problems and consequently rejected it within 2 weeks.

Meanwhile, 45% of Directory of Open Access Journals (DOAJ) publishers that completed the review process, accepted the paper, a statistic that DOAJ founder Lars Bjørnshauge, a library scientist at Lund University in Sweden, finds “hard to believe”.

The Guardian

Read The Full Article

Next

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.